# The Exploreration of the Management for the Positive IAA in Patients With Type 2 Diabetes After Premix Insulin Therapy

> **NCT05578352** · NA · UNKNOWN · sponsor: **Nanjing First Hospital, Nanjing Medical University** · enrollment: 20 (estimated)

## Conditions studied

- Type 2 Diabetes Mellitus

## Interventions

- **OTHER:** Add oral hyppoglycemia drug
- **OTHER:** Add GLP-1 receptor agonist
- **OTHER:** Change insulin

## Key facts

- **NCT ID:** NCT05578352
- **Lead sponsor:** Nanjing First Hospital, Nanjing Medical University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2022-08-05
- **Primary completion:** 2023-01-31
- **Final completion:** 2023-01-31
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2022-10-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05578352

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05578352, "The Exploreration of the Management for the Positive IAA in Patients With Type 2 Diabetes After Premix Insulin Therapy". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05578352. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*